A comprehensive validation of very early rule-out strategies for non-ST-segment elevation myocardial infarction in emergency departments: protocol for a multicentre prospective cohort study

Masafumi Tada, Hiroyuki Azuma, Naoki Yamada, Ken-Ichi Kano, Hideya Nagai, Shigenobu Maeda, Hiroshi Ishida, Takahiko Aoyama, Ryota Okada, Takahisa Kawano, Taketsune Kobuchi, Hiroyasu Uzui, Hideyuki Matano, Hose Iwasaki, Koji Maeno, Yoshimitsu Shimada, Hiroyuki Yoshida, Masaki Ando, Yoshimasa Murakami, Naotsugu IwakamiSanae Kishimoto, Taku Iwami, Hiroshi Tada, Andrew Chapman, Nicholas Mills, Hiroyuki Hayashi, Toshi A Furukawa, Norio Watanabe

Research output: Contribution to journalArticlepeer-review

Abstract / Description of output

INTRODUCTION: Recent advances in troponin sensitivity enabled early and accurate judgement of ruling-out myocardial infarction, especially non-ST elevation myocardial infarction (NSTEMI) in emergency departments (EDs) with development of various prediction-rules and high-sensitive-troponin-based strategies (hs-troponin). Reliance on clinical impression, however, is still common, and it remains unknown which of these strategies is superior. Therefore, our objective in this prospective cohort study is to comprehensively validate the diagnostic accuracy of clinical impression-based strategies, prediction-rules and hs-troponin-based strategies for ruling-out NSTEMIs.

METHODS AND ANALYSIS: In total, 1500 consecutive adult patients with symptoms suggestive of acute coronary syndrome will be prospectively recruited from five EDs in two tertiary-level, two secondary-level community hospitals and one university hospital in Japan. The study has begun in July 2018, and recruitment period will be about 1 year. A board-certified emergency physician will complete standardised case report forms, and independently perform a clinical impression-based risk estimation of NSTEMI. Index strategies to be compared will include the clinical impression-based strategy; prediction rules and hs-troponin-based strategies for the following types of troponin (Roche Elecsys hs-troponin T; Abbott ARCHITECT hs-troponin I; Siemens ADVIA Centaur hs-troponin I; Siemens ADVIA Centaur sensitive-troponin I). The reference standard will be the composite of type 1 MI and cardiac death within 30 days after admission to the ED. Outcome measures will be negative predictive value, sensitivity and effectiveness, defined as the proportion of patients categorised as low risk for NSTEMI. We will also evaluate inter-rater reliability of the clinical impression-based risk estimation.

ETHICS AND DISSEMINATION: The study is approved by the Ethics Committees of the Kyoto University Graduate School and Faculty of Medicine and of the five hospitals where we will recruit patients. We will disseminate the study results through conference presentations and peer-reviewed journals.

Original languageEnglish
Pages (from-to)e026985
JournalBMJ Open
Volume9
Issue number9
DOIs
Publication statusPublished - 3 Sept 2019

Fingerprint

Dive into the research topics of 'A comprehensive validation of very early rule-out strategies for non-ST-segment elevation myocardial infarction in emergency departments: protocol for a multicentre prospective cohort study'. Together they form a unique fingerprint.

Cite this